ASYMS-SERAT: A Side-Effect Risk Assessment Tool to Predict Chemotherapy Related Toxicity in Patients with Cancer Receiving Chemotherapy.
Julie CowieKevin SwinglerClare LeadbetterRoma MaguireKathryn McCallNora KearneyPublished in: HEALTHINF (2) (2008)
Keyphrases
- breast cancer
- assessment tool
- high risk
- prostate cancer
- cancer patients
- breast cancer patients
- dce mri
- clinical diagnosis
- cancer treatment
- logistic regression
- outcome prediction
- early detection
- colorectal cancer
- disease progression
- computer aided diagnosis
- early diagnosis
- computer aided
- panel data
- medical practitioners
- decision making
- acute coronary syndrome
- lung cancer
- patient data
- risk factors
- learning experience
- learning environment